Fred Alger Management, LLC Zymeworks Inc. Transaction History

Fred Alger Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$29.83 - $56.81 $458,487 - $873,169	-15,370 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$39.12 - $54.99 $13,535 - $19,026	-346 Reduced 2.2%	15,370 $726,000
Q3 2020 Nov 13, 2020	SELL	$29.21 - $46.58 $241,975 - $385,868	-8,284 Reduced 34.52%	15,716 $732,000
Q2 2020 Aug 14, 2020	BUY	$33.67 - $40.0 $134,680 - $160,000	4,000 Added 20.0%	24,000 $866,000
Q1 2020 May 15, 2020	SELL	$24.28 - $49.8 $48,560 - $99,600	-2,000 Reduced 9.09%	20,000 $709,000
Q4 2019 Feb 14, 2020	BUY	$24.84 - $45.46 $546,480 - $1 Million	22,000 New	22,000 $1 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $906M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.